tetano
Editor, Senior Moderator
Discov Med
. Mar-Apr 2021;31(163):57-60.
Efficacy of Remdesivir for COVID-19
Hongming Zhang[SUP] 1 [/SUP], Jibei Chen[SUP] 1 [/SUP], Xiyong Wang[SUP] 2 3 [/SUP], Baoan Chen[SUP] 4 3 [/SUP]
Affiliations
Abstract
Remdesivir is a broad-spectrum antiviral agent. With the rapid spread of Coronavirus disease 2019 (COVID-19) globally, remdesivir is taking the spotlight for COVID-19 treatment. Despite the promising signs of anti-CoV activity in several preclinical and clinical studies, more data of remdesivir in the treatment of COVID-19 is still needed for evaluating its efficacy.
. Mar-Apr 2021;31(163):57-60.
Efficacy of Remdesivir for COVID-19
Hongming Zhang[SUP] 1 [/SUP], Jibei Chen[SUP] 1 [/SUP], Xiyong Wang[SUP] 2 3 [/SUP], Baoan Chen[SUP] 4 3 [/SUP]
Affiliations
- PMID: 34965372
Abstract
Remdesivir is a broad-spectrum antiviral agent. With the rapid spread of Coronavirus disease 2019 (COVID-19) globally, remdesivir is taking the spotlight for COVID-19 treatment. Despite the promising signs of anti-CoV activity in several preclinical and clinical studies, more data of remdesivir in the treatment of COVID-19 is still needed for evaluating its efficacy.
